On this week’s Tech Nation, Andrew Keen talks about “How to fix the Future”. And on Tech Nation Health, Dr. Steve Mento from Conatus Pharmaceuticals talks about our livers and their scientific work in treating NASH and Cirrhosis of the liver. Also, Chief Correspondent Daniel Kraft describes the social determinants of health. Yes, it makes a difference.
On this week’s Tech Nation, a full hour of Tech Nation Health, reimagining the future of health and healthcare with the emergence of new technologies. DR. DANIEL KRAFT, Chief Correspondent for Tech Nation Health talks about the future of Surgery and Other Interventions. Purdue Professor, DR. PHIL LOW, the Director of Purdue Center for Drug Discovery and Chief Scientific Officer of Endocyte, talks about why it’s hard to surgically remove all the cancerous tissue, and a technology that can change that. And DR. RICHARD KUHN, the Director of the Purdue Institute for Inflammation, Immunology and Infectious Disease. He was the first to discover the structure of the Zika virus, and he compares it to other viruses, like Polio and HIV.
On this week’s Tech Nation, with an overview of CES 2018, Rick Kowalski, the Manager of Industry and Business Intelligence at the Consumer Technology Association. And going beyond gadgets, Arizona State professor Cody Friesen (“Free-senn”) tells us how his company, Zero Mass Water, is building hydropanels, producing water from sunlight and air. And in healthcare, Dr. Neal Kassell (“Kaas-sell”) talks about the global potential and the challenges focused ultrasound.
On this week’s Tech Nation, members of the CES 2018 panel “Who Owns Athlete’s Data?” Dr. Leslie Saxon, from the Keck School of Medicine at USC, and Eric Winston, the President of the NFL Players Association. Dave Aufhauser, Managing Director, Sports and Entertainment at Intel on the fan experience with live 360 Virtual Reality. And Guy Kawasaki with a vision of our futures with autonomous vehicles.
On this week’s Tech Nation, Aaron Horowitz and Hannah Chung, Co-Founders of Sproutel and Designers of My Special AFLAC Duck, for children with cancer. Then on Tech Nation Health, Dr. Todd Brady, CEO of Aldeyra describes their work on a disease which affects one-third of people. It led to a new drug helping patients with a very rare disease - Sjögren (“Show-gren”) -Larsson Syndrome
On this week’s Tech Nation, Jaron Lanier talks about “Dawn of the New Everything: Encounters with Reality and Virtual Reality”. Then on Tech Nation Health, Dr. Hartmut Ehrlich, the CEO opf Abivax, describes their efforts to keep HIV undetectable for longer and longer periods, and Chief Correspondent Dr. Daniel Kraft explores the future of going to the doctor.
On this week’s Tech Nation, how video on your smartphone is the next generation of focus groups. We’ll hear from Patricia Roller, the CEO of Vidlet(VID-LETT). Then on Tech Nation Health, the link between Down syndrome and Alzheimer’s Disease, Dr. Jerold Chun is a Professor and Director of Neuroscience Drug Discovery at Sanford Burnham Prebys Medical Discovery Institute.
On this week’s Tech Nation, “The NPR Math Guy”, Keith Devlin, tells us about Finding Fibonacci: The Quest to Rediscover the Forgotten Mathematical Genius Who Changed the World”. Then on Tech Nation Health, chief correspondent Dr. Daniel Kraft tells us about the winners of the Qualcomm Tricoder Xprize - StarTrek medicine isn’t fiction any more.
On this week’s Tech Nation, former Google CEO and Alphabet Executive Chair, Eric Schmidt along with former Senior Vice President for Products, Jonathan Rosenberg talk about “How Google Works”.
Then on Tech Nation Health, faster diagnostics for the 25 species of bacteria which cause Sepsis. John McDonough, the CEO of T2 Biosystems, talks about their efforts in Sepsis and other new diagnostics for candida and Lyme disease.
On this week’s Tech Nation, Moira speaks with Steven Johnson, the Author, “Wonderland: How Play Made the Modern World.” Then on Tech Nation Health, chief correspondent Dr. Daniel Kraft talks about the future of cancer – its prevention, early detection and emergent treatments. And Dr. Niclas Stiernholm, the President & CEO of Trillium Therapeutics, tells us about identifying cancer cells so that the immune system can remove them.